Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 8/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | BACE1 | P56817 | 1/20 | 0.45 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.42 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dodecylamine SCHEMBL1658483 | 1.00 | DNM1 (0.46) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Dodecylamine SCHEMBL1658481 | 1.00 | DNM1 (0.46) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Octadecylamine SCHEMBL1656187 | 1.00 | DNM1 (0.46) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Sorbic Acid SCHEMBL28080353 | 0.98 | ACHE (0.46) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Sorbic Acid SCHEMBL13734145 | 0.91 | ACHE (0.52) | MEN1KMT2AALDH1A1TSHRPTPN1 | |
| Sorbic Acid SCHEMBL13734143 | 0.91 | ACHE (0.52) | MEN1KMT2AALDH1A1TSHRPTPN1 | |
| Octadecylamine SCHEMBL28409810 | 0.85 | DNM1 (0.59) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Dodecylamine SCHEMBL7596348 | 0.85 | DNM1 (0.59) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Dodecylamine SCHEMBL7596339 | 0.85 | DNM1 (0.59) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Sorbic Acid SCHEMBL9156385 | 0.85 | ACHE (0.53) | PTPN1ACHEBACE1HCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4239000-A1 | COMPOSITION FOR FORMING LOW DIELECTRIC CONSTANT RESIN, LOW DIELECTRIC MEMBER, AND ELECTRONIC DEVICE USING SAME | JNC Corporation (JP) | 2023-09-06 | — | — | EP | disclosed |
| CN-115989248-A | Composition for forming low dielectric constant resin, low dielectric member, and electronic device using the low dielectric member | 捷恩智株式会社 | 2023-04-18 | — | — | CN | disclosed |
| CN-115850580-A | Composition for forming low dielectric constant resin and use thereof | 捷恩智株式会社 | 2023-03-28 | — | — | CN | disclosed |
| WO-2022092063-A1 | COMPOSITION FOR FORMING LOW DIELECTRIC CONSTANT RESIN, LOW DIELECTRIC MEMBER, AND ELECTRONIC DEVICE USING SAME | JNC株式会社 | 2022-05-05 | — | — | WO | disclosed |
| US-8168734-B2 | Lateral alpha-substituted acrylate compound and polymer thereof | JNC CORPORATION (JP) | 2012-05-01 | — | — | US | disclosed |
| US-20110144293-A1 | LATERAL ALPHA-SUBSTITUTED ACRYLATE COMPOUND AND POLYMER THEREOF | CHISSO CORPORATION (JP) | 2011-06-16 | — | — | US | disclosed |
| US-7919648-B2 | Lateral α-substituted acrylate compound and polymer thereof | CHISSO CORPORATION (JP) | 2011-04-05 | — | — | US | disclosed |
| US-20070134447-A1 | Lateral a-substituted acrylate compound and polymer thereof | CHISSO CORPORATION | 2007-06-14 | — | — | US | disclosed |
| US-7157124-B2 | Polymerizable compounds and their polymers | CHISSO PETROCHEMICAL CORPORATION (JP) | 2007-01-02 | — | — | US | disclosed |
| US-7070838-B2 | Liquid crystalline compound, liquid crystal composition and their polymers | CHISSO PETROCHEMICAL CORPORATION (JP) | 2006-07-04 | — | — | US | disclosed |
| US-20050007541-A1 | Liquid crystalline compound, liquid crystal composition and their polymers | JNC PETROCHEMICAL CORPORATION (JP) | 2005-01-13 | — | — | US | disclosed |
| US-20040222403-A1 | Polymerizable compounds and their polymers | JNC PETROCHEMICAL CORPORATION (JP) | 2004-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110144293-A1 | LATERAL ALPHA-SUBSTITUTED ACRYLATE COMPOUND AND POLYMER THEREOF | LEF1, AFF1, CNKSR1 | DNM1 1563/4885MEN1 771/4885KMT2A 1856/4885 |
| US-20070134447-A1 | Lateral a-substituted acrylate compound and polymer thereof | AFF1, CNKSR1, LEF1 | DNM1 2157/4885MEN1 531/4885KMT2A 922/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.